NCT02596152

Brief Summary

The effects of mini-trampoline training on balance, cardiorespiratory fitness, strength and neuropsychological parameters in an overweight or obese population are unknown. The aim of this 2-arm randomized controlled trial is to compare the effects of a 12-week mini-trampoline training and a 12-week nordic walking training on balance, fitness and strength in overweight/obese individuals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2015

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 30, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 4, 2015

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2017

Completed
Last Updated

November 16, 2020

Status Verified

November 1, 2020

Enrollment Period

1.2 years

First QC Date

October 30, 2015

Last Update Submit

November 13, 2020

Conditions

OverweightObesity

Keywords

balancestrengthbarriers towards exercisequality of lifebody dissatisfactionexecutive functionseating behaviorfitness

Outcome Measures

Primary Outcomes (1)

  • Postural sway

    COPspeed (Center of pressure speed measured on a force plate in cm/sec) measured on a force plate in quiet stance with eyes closed

    assessed twice: before and after the intervention (12 weeks)

Secondary Outcomes (20)

  • peak oxygen uptake

    assessed twice: before and after the intervention (12 weeks)

  • submaximal heart rate at 50 Watts

    assessed twice: before and after the intervention (12 weeks)

  • maximal work

    assessed twice: before and after the intervention (12 weeks)

  • dynamic core strength

    assessed twice: before and after the intervention (12 weeks)

  • lower body explosive strength

    assessed twice: before and after the intervention (12 weeks)

  • +15 more secondary outcomes

Study Arms (2)

Mini-trampoline

EXPERIMENTAL

participants allocated to this group will participate in a 12-week mini-trampoline group instructed training twice a week.

Other: mini-trampoline

Nordic Walking

ACTIVE COMPARATOR

participants allocated to this group will participate in a 12-week Nordic Walking group instructed training twice a week.

Other: Nordic Walking

Interventions

mini-trampolineOTHER

Intervention period lasts 12 weeks, training is group instructed, twice weekly. Training sessions are one hour each. The training intensity of the two interventional arms is comparable. The training progression is defined in advance.

Mini-trampoline
Nordic WalkingOTHER

Intervention period lasts 12 weeks, training is group instructed, twice weekly. Training sessions are one hour each. The training intensity of the two interventional arms is comparable. The training progression is defined in advance.

Nordic Walking

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18-55 years
  • Body Mass Index ≥25 kg/m2
  • ≤ 1h regular exercise/ physical activity per week

You may not qualify if:

  • cardiovascular or other chronic diseases not permitting sports participation
  • inability to follow the procedures of the study (e.g. due to dementia)
  • neurological disorders limiting balance or medications impairing balance
  • hypertensive blood pressure not permitting exercise (\>180/100 mmHg)
  • medication: beta-blocking agents which reduce cardiac adaption abilities to exercise
  • known pregnancy with contraindications for exercise according to the guidelines of the American College of Obstetricians and Gynecologists

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Basel, Department of Sport, Exercise and Health

Basel, 4052, Switzerland

Location

MeSH Terms

Conditions

OverweightObesityFeeding Behavior

Interventions

Nordic Walking

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior, AnimalBehavior

Intervention Hierarchy (Ancestors)

WalkingLocomotionMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExerciseMotor Activity

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof. Dr. Arno Schmidt-Trucksäss

Study Record Dates

First Submitted

October 30, 2015

First Posted

November 4, 2015

Study Start

August 1, 2015

Primary Completion

October 1, 2016

Study Completion

September 1, 2017

Last Updated

November 16, 2020

Record last verified: 2020-11

Locations

CH(1)